Federal Cannabis Rescheduling Moves the Needle Without Rewriting the Rules Federal Cannabis Rescheduling Moves the Needle Without Rewriting the Rules

Federal Cannabis Rescheduling Moves the Needle Without Rewriting the Rules

The U.S. Department of Justice's April 23 announcement placing certain FDA-approved marijuana products and state-licensed medical cannabis into Schedule III of the Controlled Substances Act is real.